PDA Technical Report No. 54-2(TR 54-2) Implementation of Quality Risk Management for Pharmaceutical & Biotechnology Manufacturing Operation:Annex 1: Case Study Examples for Quality Risk Management in Packaging & Labeling (single user digital version)

Published
Jun 2013
ISBN
9780939459551
Pages
63
PDA Item Number
43504

Premium Members: to claim your annual free technical document download, email membership@pda.org and indicate the document you wish to claim.

Format
PDF Single user
Member Price
$180.00
Nonmember Price
$325.00
Government Price
$180.00

The first Annex to Technical Report No. 54: Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations provides specific case studies on how to apply quality risk management (QRM) to pharmaceutical manufacturing, specifically packaging and labeling operations.

This report is intended to align with ICH Q9 and is one in a series of similar documents that provide additional examples of how to apply risk management tools across the product supply chain.

Technical Report No. 54-2 was drafted by an all-volunteer team of experts representing companies like Merck, Amgen and Genentech.

Available to download
Format: PDF (1 file 1.52 MB)

Click here to view the digital downloading instruction and Terms of Usage

*To purchase licensing, please contact PDA at info@pda.org.

Click here to order paper ship version (Item no. 01054.2)

Table of Contents

Table of Contents:

Click here to download >>> Detailed Table of Contents
  1. Introduction
  2. Glossary of Terms
  3. Case Study 1: Control of Liquid Drug Product During Packaging
  4. Case Study 2: Risks Associated with Secondary Packaging Components Production
  5. Case Study 3: Control of Logistics Channels for Liquid Product in Bulk Hold Pending Packaging
  6. Case Study 4: Risks in Packaging, Handling and Transport of Liquid Filled Glass Syringe
  7. Case Study 5: Control of Logistics Channels for Refrigerated Bulk Solid Oral Dose
  8. Conclusion
  9. Additional Reading
  10. References
  • Figures and Tables Index
  • About the Authors

    Ghada Haddad, MBA, Chair Genentech/Merck

    Mike Boyson, Millennium: The Takeda Oncology Company

    Boriana Cavicchia, URS

    Mary Foster, PharmD, Aphena Pharma Solutions

    Mark Frankcom, Yellowscape Consulting

    Martin Hunter, Amgen

    Bill Leung, Genentech

    Liza Munda, Genentech

    Mindy Pang, Merck

    James Robinson, Lachman Consultants

    David Thatcher, Amgen